• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9600TFX23A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Obstruction/Occlusion (2422)
Event Date 08/26/2021
Event Type  Injury  
Manufacturer Narrative
Investigation is still ongoing.
 
Event Description
As reported by implant patient registry, post operative day (pod) 1 of a 23mm sapien 3 valve in a pre-existing pulmonic conduit the valve in the pulmonic position, the s3 valve was explanted due to st changes caused by compression of one of the branches feeding the lad, which was later found to be coming off the right coronary cusp.Post deployment, the team struggled to get good images of the left coronary system due to the double pre-stents with the sapien 3 valve inside.The proximal left coronary system was difficult to visualize, and the ekg showed st changes.The patient was hemodynamically stable, however, the decision was made to move to the floor and monitor the patient and troponin levels.One of the branches feeding the lad was later found to be coming off the right coronary cusp, which the team believes must have been compressed causing the st changes.Over night, the troponin levels continued to elevate.The decision was made to bring the patient to the operating room and remove the pre-stent and sapien 3 valve then sew in a surgical valve.This was performed and the patient left the operating room in stable condition.
 
Manufacturer Narrative
Per the instructions for use (ifu), coronary flow obstruction is a potential adverse event associated with the tpvr procedure.The ifu cautions that assessment for coronary compression risk prior to valve implantation is essential to prevent the risk of severe patient harm.Coronary occlusion can result in myocardial ischemia or infarction due to obstruction of the coronary blood flow and may require intervention (e.G.Pci).There are multiple patient factors that could contribute to coronary occlusion including a minimal distance between the transcatheter heart valve (thv) landing zone and the coronary artery.The edwards thv training manuals advise the operator on pre-procedure assessment of the pulmonic thv target implantation site, aortic valve, root, and coronary anatomy.Physicians are extensively trained by edwards before they are qualified to use the thv.Training includes patient screening, device preparation, approach, deployment, imaging, procedure-specific training manuals and proctored procedures.The physician is instructed to evaluate this risk early in the patient screening process in all patients.In this case, the cause of the coronary artery compression cannot be confirmed.However, there was no allegation or indication a device malfunction contributed to this adverse event.Per report, it was difficult to get good images of the left coronary system for coronary compression assessment due to the patient having double pre-stents in the landing zone.The ifu and training manuals have been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.No corrective or preventative actions are required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE
Type of Device
PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key12524371
MDR Text Key273085133
Report Number2015691-2021-05318
Device Sequence Number1
Product Code NPV
UDI-Device Identifier00690103194340
UDI-Public(01)00690103194340(17)220429
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P200015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/24/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/29/2022
Device Model Number9600TFX23A
Device Catalogue Number9600TFX23A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received11/22/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/05/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-